Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

CEO Emma Walmsley’s 40-bln-pound 2031 sales target looks fanciful after another disappointing drug trial. A healthy balance ...

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other ...

GSK is laying out €250 million to bolster vaccine manufacturing with a new facility to help make free-dried shots, including for shingles and RSV.

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now.In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other ...